Form D · Other Technology

AffyImmune Therapeutics, Inc.

Natick, MA · CIK 0001752966

Offering snapshot reported Nov 28, 2018 · SEC filing

Reported sold
$7.86M
Offering amount: $14.6M
Investors reported
2
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 31, 2018
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$3.93M$7.86MSep 13, 2018: $999,999.00Sep 13, 2018Nov 28, 2018: $7,857,674.00Nov 28, 2018

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$999,999 → $7,857,674

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 28, 2018Amendment$7,857,674$6,857,675vs Sep 13, 20182SEC filing
Sep 13, 2018Initial$999,999No comparison2SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-321277

Source: Form D, filed Nov 28, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Moonsoo Jin Director, Executive
Gang Song Director, Executive
Hong Fang Song Director

Issuer details

Industry: Other Technology (See others in industry)

Address:
12 Michigan Dr
Natick, MA, 01760